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Background: Genome-wide association studies (GWAS) have recently identified many new genetic variants
associated with the development of type 2 diabetes. Many of these variants are in introns of known genes or
between known genes, suggesting they affect the expression of these genes. The regulation of gene expression is
often tissue and context dependent, for example occurring in response to dietary changes, hormone levels, or
many other factors. Thus, to understand how these new genetic variants associated with diabetes risk may act, it is
necessary to understand the regulation of their cognate genes.
Results: We identified fourteen type 2 diabetes-associated genes discovered by the first waves of GWAS for which
there was little prior evidence of their potential role in diabetes (Adam30, Adamts9, Camk1d, Cdc123, Cdkal1,
Cdkn2a, Cdkn2b, Ext2, Hhex, Ide, Jazf1, Lgr5, Thada and Tspan8). We examined their expression in metabolically
relevant tissues including liver, adipose tissue, brain, and hypothalamus obtained from mice under fasted, non-
fasted and high fat diet-fed conditions. In addition, we examined their expression in pancreatic islets from these
mice cultured in low and high glucose. We found that the expression of Jazf1 was reduced by high fat feeding in
liver, with similar tendencies in adipose tissue and the hypothalamus. Adamts9 expression was decreased in the
hypothalamus of high fat fed mice. In contrast, the expression of Camk1d, Ext2, Jazf1 and Lgr5 were increased in the
brain of non-fasted animals compared to fasted mice. Most notably, the expression levels of most of the genes
were decreased in islets cultured in high glucose.
Conclusions: These data provide insight into the metabolic regulation of these new type 2 diabetes genes that will
be important for determining how the GWAS variants affect gene expression and ultimately the development of
type 2 diabetes.
Keywords: Type 2 diabetes, Gene expression, Genome-wide association, High fat diet, Feeding and fasting, Mice,
Pancreatic islets, Glucotoxicity* Correspondence: susanne.clee@ubc.ca
1Department of Cellular and Physiological Sciences, Life Sciences Institute,
University of British Columbia, Vancouver, Canada
Full list of author information is available at the end of the article
© 2013 Ho et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Ho et al. BMC Genetics 2013, 14:10 Page 2 of 12
http://www.biomedcentral.com/1471-2156/14/10Background
Nearly 350 million people world-wide are currently
affected by diabetes, and the number of people with type
2 diabetes mellitus is increasing at an alarming rate [1].
Type 2 diabetes results when the β-cells of the pancreas
are no longer capable of producing sufficient insulin to
meet the body’s demands. Thus β-cell dysfunction is a
key component of type 2 diabetes pathology. Although
the increased prevalence of obesity and resulting insulin
resistance is contributing to the increased prevalence of
type 2 diabetes, many obese individuals are insulin re-
sistant but do not develop diabetes [2]. Genetic factors,
many of which have been proposed to affect β-cell
function, play an important role in determining an
individual’s risk within this context [3-6]. In a small
number of individuals, type 2 diabetes is caused by rare
single gene mutations, but for most individuals type 2
diabetes results from the combined effects of many com-
mon single-nucleotide polymorphisms (SNPs), each of
which have a small effect on risk and likely interact
with each other and with environmental and lifestyle
factors [7].
Genome-wide association studies (GWAS) have re-
cently revealed many novel SNPs associated with type 2
diabetes. These include SNPs located in the regions near
TCF7L2, HHEX-IDE, EXT2, FTO, SLC30A8, IGF2BP2,
CDKAL1, and CDKN2A-CDKN2B [8-13]. A second
phase of studies identified many additional variants,
including those near JAZF1, TSPAN8-LGR5, THADA,
ADAMTS9, NOTCH2-ADAM30, CDC123-CAMK1D, and
KCNQ1 [14,15]. The two genes in which common
variants were previously convincingly associated with
type 2 diabetes, PPARG and KCNJ11, were also identi-
fied in these GWAS [12,16,17]. More recently, numerous
other SNPs have been identified in additional GWAS
and meta-analyses [18].
The association between variants in TCF7L2 and type
2 diabetes, which was identified initially in pre-GWAS
studies, has been almost universally replicated and has
the largest effect on diabetes risk [19,20]. This transcrip-
tion factor is known to play a role in WNT signalling
and pancreatic development [20]. Variation in FTO has
been shown to influence risk of type 2 diabetes through
its effects on promoting obesity [8]. Variation within
IDE, the insulin degrading enzyme, has previously been
associated with risk of type 2 diabetes in both humans
and rats, although these findings were not consistently
replicated [21-26]. SLC30A8 is a zinc transporter
expressed in β-cells and is known to be involved in insu-
lin granule formation and insulin secretion [27-29].
IGF2BP2 encodes insulin like growth factor 2 mRNA
binding protein 2, which plays a role in RNA stability
and localization and has been suggested to affect pancre-
atic development [30]. NOTCH2 is a transcription factorimportant for pancreatic development [31] and the
Notch pathway plays a role in adult beta-cell survival
[32]. KCNQ1 is a voltage-gated potassium channel that
has been shown to affect insulin secretion [33]. However,
the mechanisms by which the remainder of these genes
affect diabetes risk are largely unknown. Thus, we
sought to obtain evidence of their potential role in meta-
bolic disease.
Most of the diabetes-associated SNPs were found in
non-coding regions of the genome and are thus likely to
affect gene regulation. In order to understand how these
genes affect type 2 diabetes and how the SNPs associated
with diabetes affect gene expression, we need to first
understand the physiological processes that regulate the
expression of these genes. We examined the expression
patterns of these potential new diabetes-susceptibility
genes to determine which are expressed in tissues im-
portant for the development of type 2 diabetes. This
may also suggest the potential mechanism(s) by which
alterations in these genes affect diabetes risk (e.g. insulin
secretion versus insulin sensitivity). We also sought to
determine whether any of these genes are regulated by
conditions known to alter the expression of metabolic-
ally relevant genes. We examined the expression of these
genes under fasting and non-fasting conditions (e.g. in
response to insulin), which might be altered if they affect
peripheral insulin sensitivity. Consumption of diets high
in fats and sugars is associated with risk of developing
type 2 diabetes [34] and many genes that are critical for
β-cell function are regulated by glucose [35]. Thus, we
also compared their expression in fasted mice consum-
ing a normal chow diet or a diet high in fat and sugar,
and examined the expression of these genes in mouse
pancreatic islets cultured under low and high glucose
concentrations. Here we show that most of the diabetes-
associated genes are expressed in many metabolically
relevant tissues and the expression levels of several of
these genes were decreased by high fat feeding or were
increased in the fed state in the brain. In addition, we
found most of these genes are down-regulated by
increased glucose concentrations in mouse islets.
Results
Tissue distribution of gene expression
High throughput gene expression profiling has pre-
viously been performed to identify gene expression
patterns across a wide variety of tissues [36], but such
microarray-based data must be complemented by accur-
ate and quantitative analysis. Thus, we performed qPCR
analysis of the recently identified diabetes susceptibility
genes across a panel of tissues (Table 1) to determine
their relative expression levels in each tissue. Most of
these genes were expressed in many metabolically rele-
vant tissues including pancreatic islets, liver, white and
Table 1 Relative expression patterns of GWAS diabetes genes in chow fed mice
Isl Brain Hypo P-AT BAT Liver SkM Hrt St SI LI Lung Kid Spl Ov Ut Thy
Adam30 NE Low NE Avg NE NE Avg Avg Avg NE NE NE NE Avg NE NE Avg
Adamts9 Low Low Avg Avg Avg Avg NE Avg Avg NE Avg Avg Avg Avg High High Avg
Camk1d Avg Avg Avg Avg Avg Avg Low Avg Avg NE High NE Avg Avg Avg Avg High
Cdc123 Avg Avg Avg Avg Avg Avg Low Avg Avg NE Avg Low Avg Avg High Avg Avg
Cdkal1 Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Low Avg Avg Avg Avg Avg
Cdkn2a (Arf ) Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg Avg
Cdkn2a NE NE NE Avg Avg NE NE NE NE NE Avg NE Avg Avg NE NE Low
Cdkn2b High Avg Avg Avg Avg Avg NT Avg NT High NT NT Avg NT High Low Low
Ext2 Low Avg Avg Avg Avg Avg Low Avg Avg Avg Avg Low Avg Avg High Avg Avg
Hhex Low Avg Avg Avg Avg High Low Avg Low Low Avg Low Avg High Avg High Avg
Ide Avg Avg Avg Avg High Avg NT Avg NT Avg NT NT NT NT High Low Low
Jazf1 Avg Avg Avg Avg High NE NE Avg Low Low Avg Low Low Low Avg High Avg
Lgr5 NE High Avg Avg Low Avg Low Avg Avg NE Avg Low NE Avg High High Avg
Thada Avg Avg Avg Avg Avg Avg NE Avg Avg NE Avg Low Avg Avg High Avg Avg
Tspan8 Low Low Low Avg Avg Low Low Avg High NE High NE Avg High Avg High Low
Expression levels are relative within a gene, but comparisons between genes cannot be made. Isl = islets, Hypo = hypothalamus, P-AT = parametrial white adipose
tissue, BAT = brown adipose tissue, SkM = skeletal muscle (soleus),Hrt = heart, St = stomach, SI = small intestine (duodenum), LI = large intestine (distal), Kid =
kidney, Spl = spleen, Ov = ovary, Ut = uterus, Thy = thymus. NE = not expressed, Ct values within 2 cycles of negative control; avg. = average expression (within 5-
fold (2.3 cycles) of average expression across all tissues); high = >5 fold higher (Ct values >2.3 cycles lower) than average expression; low = >5 fold lower






















Figure 1 Regulation of new diabetes genes by nutritional
status in the liver. Data are shown as fold-change relative to those
observed in the fasted chow-fed mice. The number of samples per
group for the fasted chow-fed mice, fasted HFD-fed mice and non-
fasted (fed) chow-fed mice, respectively are Adamts9 (7, 7, 4), Hhex
(7, 5, 5), Jazf1 (7, 7, 8). P-values are shown for the indicated group
compared to the fasted chow-fed controls. Data are shown as the
fold change (2ΔΔCt) ± 2ΔΔCt±SE [87]. * P < 0.05, ** P < 0.01.
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addition, most were expressed in the hypothalamus and
in regions of the brain outside the hypothalamus. Few of
these genes were robustly expressed in skeletal muscle
or small intestine. We detected expression of all the
genes in pancreatic islets except Adam30, Cdkn2a, and
Lgr5. Together, these studies point to several metabolic-
ally relevant tissues as potential key sites of action of the
diabetes susceptibility genes identified by the GWAS.
Regulation of GWAS diabetes genes by dietary status in
the liver
To determine whether these new type 2 diabetes suscep-
tibility genes are regulated by nutritional manipulations,
we examined whether there was a change in their ex-
pression between tissues from fasted and non-fasted
chow-fed mice, or between tissues from fasted chow and
fasted high fat diet-fed mice. We used a common con-
trol group (fasted, chow-fed mice) to which the non-
fasted, chow-fed mice and the fasted, high fat diet-fed
mice were compared. As the liver is a key metabolic
organ and a major target of insulin action, we first
examined the expression of these genes in the liver
(Figure 1). The expression of Jazf1 was decreased by ap-
proximately 70% in mice fed a high fat diet compared to
chow-fed controls. Similar differences were observed for
Adamts9 (75% decrease) and Hhex (60% decrease).
Whereas we could detect expression of the Arf isoform
of Cdkn2a in chow-fed mice, its expression was detected
in only 2 samples from the high fat diet-fed mice. Incontrast to many classical transcriptional targets of insu-
lin signalling, none of the genes examined in this study
had significantly altered expression in the livers of fasted
versus non-fasted mice. Again, while it was found in
most of the liver samples from the chow-fed fasted con-
trol mice, the expression of Cdkn2a (Arf ) was detected
only sporadically in the livers of non-fasted mice. While
Cdkn2b was expressed in all the samples, its expression
did not differ between groups. No differences in
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Ext2, Ide, Lgr5, Thada, or Tspan8 (not shown), al-
though expression of Cdc123 was decreased ~35% in
high fat diet-fed mice (P = 0.07). Thus, while the hepatic
expression of some of these new diabetes genes is
regulated by chronic consumption of diets high in fat
and sugar, we do not find evidence that they are acutely
regulated in response to feeding and fasting as might be
expected for key insulin-responsive genes.Regulation of GWAS diabetes genes by dietary status in
adipose tissue
Adipose tissue is a critical insulin-responsive tissue. Fat
also produces many factors, adipokines, that may con-
tribute to whole body insulin sensitivity. We examined
whether any of these diabetes susceptibility genes are
regulated by nutritional status in adipose tissue (Figure 2).
Cdkn2b and Thada expression levels were decreased ~50
and 30%, respectively, in fasted chow versus high fat
diet-fed mice. Jazf1 expression may also be reduced
(~45%, P = 0.06, not shown). In contrast Ide expres-
sion levels were ~1.6 fold higher in high fat-fed
mice. The expression of Adam30 was decreased over
80% in fasted versus non-fasted mice, although this
did not reach statistical significance (P = 0.06). None
of the remaining genes expressed in adipose tissue
showed significant changes in expression for either
condition (Figure 2), suggesting little involvement of
these new diabetes genes in adipose tissue function.
This is in contrast to many of the newly identified


















Figure 2 Regulation of new diabetes genes by nutritional
status in adipose tissue. Data are shown as fold-change relative to
those observed in the fasted chow-fed mice (n = 7 for the fasted
chow-fed group, 6 for the fasted HFD-fed mice and 8 for the fed
chow-fed mice). P-values are for the comparison between the
indicated group and the fasted, chow-fed control mice. Data are
shown as the fold change (2ΔΔCt) ± 2ΔΔCt±SE [87]. * P < 0.05.Regulation of GWAS diabetes genes by dietary status in
the brain
Recent studies have shown important neuronal contributions
to the regulation of metabolism, insulin sensitivity and islet
function, particularly within regions of the hypothalamus
[38-41]. Thus, we examined the expression of the recently
identified type 2 diabetes susceptibility genes in the hypo-
thalamus (Figure 3) and the remainder of the brain
(Figure 4). In the hypothalamus, the expression of
Adamts9 and Camk1d were decreased by ~80%, in fasted
chow versus fasted high fat diet-fed mice (Figure 3).
Cdkn2b expression was similarly decreased, although this
did not reach statistical significance (not shown). The
mRNA levels of Jazf1 and Thada were 60-70% lower in
the high fat diet-fed mice. Lgr5 also tended to be
decreased (not shown). In fasted versus non-fasted chow-
fed mice, Cdkal1 expression was decreased by approxi-
mately 50% (Figure 3). No significant differences were
found for Cdc123, the Arf isoform of Cdkn2a, Ext2, Hhex,
Ide, Lgr5, or Tspan8.
In the remainder of the brain outside the hypothal-
amus none of the genes were significantly affected by
the consumption of the high fat diet, but strikingly many
of them were regulated by feeding/fasting status
(Figure 4). Cdkn2b expression was increased ~3-fold by
both conditions, but neither reached statistical signifi-
cance. Only four genes expressed in the brain, Cdc123,
Cdkal1, Ide, and Thada, were not affected by either ex-
perimental condition. Camk1d expression was increased
over 7-fold in non-fasted versus fasted chow-fed mice.
Jazf1 and Lgr5 expression were increased 3.5 and 4.5-
fold, respectively, in non-fasted mice. Ext2 and Hhex
had a 2 to 2.5-fold increase in expression in fasted ver-
sus non-fasted mice. Tspan8 on the other hand, had a
significant 60% decrease in expression in non-fasted ver-
sus fasted mice. Like in the liver, the expression of the
Arf isoform of Cdkn2a was low but detectable in both
chow-fed groups, but not in the mice consuming the
high fat diet. Adam30 expression was only detected in
the brains of non-fasted chow-fed mice. Together, these
results illustrate that the expression of several type 2 dia-
betes susceptibility genes can be metabolically regulated
in the brain and point to the potential importance of
neuronal function in type 2 diabetes susceptibility.
Regulation of GWAS diabetes genes by glucose in
pancreatic islets
Many of the recently discovered type 2 diabetes genes
have been suggested to affect the development and/or
function of pancreatic islets [6]. The function, growth
and survival of β-cells can be regulated acutely and
chronically by glucose [34]. Thus, we examined whether
the new type 2 diabetes susceptibility genes are regulated
by overnight incubation in low (5 mM) or high (25 mM)
























Figure 3 Regulation of new diabetes genes by nutritional status in the hypothalamus. Data are shown as fold-change relative to those
observed in the fasted chow-fed mice. The number of samples per group for the fasted chow-fed mice, fasted HFD-fed mice and non-fasted
(fed) chow-fed mice, respectively are Adamts9 (7, 5, 4), Camk1d (7, 5, 5), Cdkal1 (10, 5, 9), Jazf1 (10, 8, 7), Thada (7, 5, 5). P-values are shown for the
indicated group compared to the fasted chow-fed controls. Data are shown as the fold change (2ΔΔCt) ± 2ΔΔCt±SE [87]. * P < 0.05, ** P < 0.01.
Ho et al. BMC Genetics 2013, 14:10 Page 5 of 12
http://www.biomedcentral.com/1471-2156/14/10glucose (Figure 5). Most genes were significantly or
tended to be downregulated under conditions of high
glucose. Cdkal1, Cdkn2a (Arf, P = 0.07), Ide, Jazf1,
Camk1d, and Tspan8 (P = 0.06) expression levels were
decreased ~50-60%. Meanwhile, the expression of
Cdkn2b, Hhex (P = 0.10), Cdc123, Adamts9 (P = 0.09),
and Thada were reduced 30-40%. To ensure the islets
incubated in high glucose did not have globally






























Figure 4 Regulation of new diabetes genes by nutritional status in th
those observed in the fasted chow-fed mice. HFD = high fat diet. The num
mice and non-fasted (fed) chow-fed mice, respectively are (6, 5, 10) except
compared to the fasted chow-fed controls. Data are shown as the fold chaTxnip, which has been shown to be highly upregulated
by glucose [35] and found that its expression was still
significantly elevated in the islets cultured in high glu-
cose (Figure 5). Mouse islets consist of β-cells and
other cell types. Thus, the MIN6 β-cell line was also
examined. We found that all the genes were expressed
in this cell line (not shown), although this does not
preclude that they also are expressed in other cell














e remainder of the brain. Data are shown as fold-change relative to
ber of samples per group for the fasted chow-fed mice, fasted HFD-fed
for Adamts9 (6, 4, 10). P-values are shown for the indicated group

































































Figure 5 Regulation of new diabetes genes by glucose levels in pancreatic islets. Data are shown as fold-change, (2ΔΔCt) ± 2ΔΔCt±SE [87],
relative to those observed in the islets incubated in low (5 mM) glucose. Each group is the average of three replicates, each of which was
comprised of pooled islets from two mice. * P < 0.05, *** P < 0.001.
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The goal of the present study was to understand
whether metabolic factors affect the expression of the
genes recently implicated in the development of type 2
diabetes for which there was little prior evidence of their
potential role(s) in this disease. Although many add-
itional SNPs have been identified in subsequent GWAS
and meta-analyses [18], we focussed these studies on the
genes identified in the first waves of GWAS, as these
have been the subject of most follow-up studies to date.
Specifically, we examined acute changes in expression of
these genes in response to feeding and fasting and
longer term changes in the expression of these genes in
response to a diet high in fat and sugar, recognized as a
critical environmental risk factor for type 2 diabetes.
It has been hypothesized that most of the new genetic
variants affect β-cell function, development or survival
but not insulin sensitivity [6]. Consistent with this,
we found all of the genes except Adam30 and Cdkn2a
were expressed in pancreatic islets. These genes were
expressed, however in the transformed β-cell line,
MIN6. The expression of all the genes except Lgr5
decreased following incubation of the islets in high glu-
cose concentrations. It can thus be hypothesized that
these genes may normally play a beneficial role in islet
function, and a reduction in the expression of these
genes could contribute to glucotoxic β-cell dysfunction
or survival. However, we also found evidence that most
of the genes could have potential roles in other
metabolically-relevant tissues. Genes affecting insulin
sensitivity may be expected to be expressed in peripheralinsulin sensitive tissues, such as liver and adipose tissue,
and be responsive to metabolic status. Consumption of a
high fat diet was associated with a tendency for the ex-
pression of several of these genes to be decreased. Simi-
larly, many of the genes were regulated by feeding and
fasting. Only the two splice isoforms of Cdkn2a had no
evidence of metabolic regulation in any of the other
tissues examined.
Jazf1, also known as Tip27, encodes a transcriptional
repressor of Nr2c2, an orphan nuclear receptor of the
steroid receptor family also known as TR4 and TAK1.
Nr2c2 has been reported to modulate apoptosis [42,43]
and its loss in mice is associated with reduced mito-
chondrial function and increased oxidative stress, and
conversely with reduced adipose tissue inflammation,
hepatic steatosis and insulin resistance [44-46]. Jazf1-
mediated alterations in Nr2c2 could thus affect both in-
sulin sensitivity and β-cell function. Genetic variation in
Jazf1 has been variably associated with measures of insu-
lin sensitivity and β-cell function [47-52], and our ex-
pression data support roles for this gene in both. Jazf1
was expressed in nearly all tissues examined and its ex-
pression in islets was decreased following culture in high
glucose-containing media. Consistent with a pathogenic
role in islets, it has recently been shown that JAZF1
expression is reduced in individuals with type 2 dia-
betes or hyperglycemia, and that JAZF1 expression
was correlated with insulin secretion [53]. However, our
findings suggest the reduced expression may be a conse-
quence of their hyperglycemia, not the underlying cause.
These data are consistent, however, with a role of Jazf1 in
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develop hyperglycemia or perhaps impaired glucose toler-
ance. Jazf1 expression in the liver and hypothalamus was
decreased in mice fed the high fat diet, with the same ten-
dency in adipose tissue. The GWAS SNPs may affect the
expression of Jazf1 in adipose tissue, suggesting that its
function in this tissue may be important for its role in type
2 diabetes [54]. That we also observed changes in the ex-
pression of Jazf1 in the brain and hypothalamus, suggests
further potentially important sites of action.
Adamts9 is an anti-angiogenic factor known to be
expressed in vascular endothelial cells [55] and is
implicated in endoplasmic reticulum to Golgi transport
[56]. Although some studies have found associations be-
tween SNPs in this gene and various measures of insulin
sensitivity or secretion [49,50], many others have not
[47,48,52,57]. Microvascular structure affects both insu-
lin secretion and sensitivity [58]. Adamts9 expression
tended to be downregulated by high glucose in islets and
was decreased in the hypothalamus and liver of high fat
diet-fed mice. These data suggest that this gene may play
a role in the neural regulation of metabolism in addition
to having effects, perhaps on insulin sensitivity, in the
liver and also in islets that may be related to its role in
vascularization [59].
Hhex encodes a homeobox transcription factor known
to be involved in pancreatic and liver development
[60,61]. SNPs in HHEX have been associated with
decreased insulin secretion perhaps due to alterations in
vesicle docking [57,62-66]. Most studies have failed to
find associations between HHEX SNPs and insulin sensi-
tivity [52,57,62-64,67], although associations with insulin
clearance and hepatic insulin sensitivity have been
reported [52,64]. We found Hhex to be expressed in sev-
eral tissues besides the pancreas, with evidence of
decreased expression in the liver in response to high fat
feeding and increased expression in the brain in non-
fasted mice. These findings provide potential support for
roles of Hhex in metabolism outside the pancreas. The
GWAS SNPs associated with type 2 diabetes are located
between Hhex and Ide. There was prior evidence for a
role of Ide in type 2 diabetes [21,22,25,26]. We found Ide
expression to be increased by high fat feeding in adipose
tissue and to be decreased by the incubation of islets in
high glucose, consistent with a role of Ide in β-cell func-
tion [63]. Combined, these data suggest potential roles
for both Hhex and Ide in type 2 diabetes susceptibility.
Little is known about the potential roles of Thada in
metabolic disease. It is a gene associated with a common
chromosomal breakpoint in thyroid cancers, that may
affect cell death receptors [68]. We found widespread
expression of Thada and noted its decreased expression
in islets following culture in high glucose. Thada expres-
sion was also reduced in response to high fat feeding inboth adipose tissue and the hypothalamus. No evidence
for association of SNPs in this gene with insulin sensitiv-
ity have been found [48,49,52,57], and while most stud-
ies have not found associations with insulin secretion
[47-49,57], an association with reduced insulin secretion
in response to non-nutrient secretagogues and poten-
tially β-cell mass has been reported [50]. Our data are
consistent with a primary role of this gene in the pan-
creas in determining type 2 diabetes susceptibility, al-
though indicate it may also have effects on the
regulation of energy balance and metabolism.
Although Adam30 (A disintegrin and matrix metalloprotease
30) has been reported to be expressed only in the testis
[69], we found evidence of expression in several metabol-
ically relevant tissues including the brain, adipose tissue,
heart and stomach. It was not expressed in islets. We
observed a marked reduction of its expression in adipose
tissue collected from non-fasting animals, providing a po-
tential site of action whereby this gene may affect metab-
olism and thus type 2 diabetes risk.
In contrast to the above genes, the expression of other
genes were not widely altered aside from within pancre-
atic islets, consistent with the primary mechanism by
which they are associated with diabetes being through
alterations in islet biology. The mechanisms by which
SNPs at the CAMK1D-CDC123 locus affect diabetes
susceptibility are unknown, and it is unclear which of
these two genes is affected by the causative genetic vari-
ation. Some, but not all, studies have found associations
of SNPs at this locus with insulin secretion, while no
associations with insulin sensitivity have been found
[47-50,52,57]. There is evidence that genetic variation
near CAMK1D can affect its expression, at least in
lymphocytes [54]. The expression of both genes was
similarly reduced in islets cultured in high glucose,
suggesting the possibility that they are under common
regulatory control in these cells. We found decreased ex-
pression of Camk1d in the hypothalamus of high fat-fed
mice and increased expression in other regions of the
brain in non-fasted mice, suggesting it may affect the
neuronal control of metabolism or islet function. In
contrast, no substantial changes in Cdc123 expression in
response to feeding and fasting or high fat diet con-
sumption were observed. As the SNPs at this locus are
primarily associated with insulin secretion and the ex-
pression of both genes in islets was altered, these data
cannot distinguish which may be the causative gene.
SNPs within CDKAL1 have been associated with insulin se-
cretion and not insulin sensitivity [13,47,52,57,63,66,67,70].
Cdkal1 is a tRNA modification enzyme. Specifically, this pro-
tein is a methylthiotransferase that modifies tRNALys, stabiliz-
ing interactions between the tRNA and mRNA, decreasing
misreading of its cognate codon [70]. Mice deficient in Cdkal1
have impaired glucose tolerance and insulin secretion, and
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pression in pancreatic islets was decreased following incuba-
tion in high glucose, which could contribute to β-cell
dysfunction in settings of hyperglycemia. Interestingly, we also
found that Cdkal1 expression was reduced in the fed state in
the hypothalamus, suggesting it may have metabolic functions
in addition to those in insulin synthesis and secretion.
The GWAS have identified SNPs at the Cdkn2a-Cdkn2b
locus. The Cdkn2a (cyclin dependent kinase inhibitor 2a)
gene has two alternative splice isoforms that encode dis-
tinct proteins, Cdkn2a and Arf. The Arf isoform is
generated by the use of an upstream alternative first exon.
Both are involved in cell cycle control. We found expres-
sion of the Arf isoform to be very low in chow-fed mice
and not detectable in most tissues from high fat diet-fed
mice. We found higher levels of expression of this gene in
islets, and potential downregulation of its expression by
high glucose concentrations. In contrast, the Cdkn2a
isoform was found in a limited number of tissues and not
in islets. These data suggest that Arf might be the relevant
isoform of Cdkn2a, affecting diabetes by affecting β-cell
mass. Given the loss of expression of this gene in high fat
diet-fed mice it is tempting to speculate that this may be a
mechanism affecting high fat diet-induced metabolic dys-
function. The expression of Cdkn2b was decreased in adi-
pose tissue of high fat-fed mice. As this gene encodes a
cell cycle inhibitor, this reduced expression may reflect
increased proliferation of adipocyte precursors or perhaps
infiltrating inflammatory cells. Interestingly, Cdkn2b ex-
pression was also decreased in islets incubated in high glu-
cose, consistent with a role in the regulation of β-cell
mass and glucose-induced β-cell proliferation [73]. Thus,
as with the Hhex-Ide locus, these studies cannot distin-
guish whether Cdkn2a or Cdkn2b is the causative gene,
and actually suggest a role for both in the development of
type 2 diabetes.
Ext2 is a glycosyltranferase involved in the synthesis of
heparin sulphate, and mutations in this gene are
associated with abnormal bone growths (exostoses) [74].
This gene may also be involved in neural development
[75]. The association between SNPs in this gene and
type 2 diabetes has not been as well replicated
[10,12,13,62]. We found increased expression of this
gene in brain, suggesting a possible site of action as to
where this gene could affect diabetes risk.
Lgr5 is a seven transmembrane receptor and a mem-
ber of the rhodopsin family [76]. It is a marker of
mitotically active intestinal stem cells and potentiates
Wnt/β-catenin signalling [76,77]. This is the only gene
for which we did not find a significant decrease in ex-
pression in islets cultured in high glucose, although this
certainly does not preclude it from having a role in pan-
creatic and β-cell development. Its expression was
increased in the brains of non-fasted mice, suggestinganother potential site of action through which it may
mediate type 2 diabetes susceptibility.
Tspan8, also known as Co-029, is a cell surface protein
implicated in pancreatic, colon and liver tumors and
their metastasis, possibly through interaction with
integrins [78]. Although some studies have found
associations between SNPs in this gene and insulin sen-
sitivity or secretion [47,57], others have not [48-50,52].
Loss of this gene is associated with decreased body
weight, although there were no detectable effects on glu-
cose tolerance or insulin sensitivity [79]. In contrast to
that study which did not detect expression of this gene
in mouse pancreas [79], we found expression of this
gene in isolated pancreatic islets and suggested regula-
tion of its expression by glucose. Tspan8 expression was
significantly decreased in brains of fed compared to
fasted chow-fed mice, suggesting it may also have a role
in the neural control of metabolism.
In summary, we have identified nutritional regulation
of many of the newly found type 2 diabetes-associated
genes. As these studies were performed with a relatively
small number of samples, it should be noted that smaller
changes in expression may also exist that we had insuffi-
cient power to detect. These data provide support for
the involvement of these newly identified type 2 diabetes
susceptibility genes in β-cell function and also suggest
potential roles for many of them in peripheral tissues,
notably in the brain and hypothalamus, highlighting the
potential importance of neuronal regulation of metabol-
ism and islet function to type 2 diabetes [38-41]. Our
study also highlights the tissue-specific regulation of
these genes (changes in one or more tissues where the
gene is expressed but not in all tissues), suggesting that
the SNPs identified in the GWAS studies may need to
be examined in the appropriate tissues and under several
metabolic contexts [37]. Indeed, recent studies aimed at
identifying genetic variants that affect gene expression
(eQTLs) have found varying effects of these SNPs on
gene expression in different tissues, particularly for SNPs
located within not between genes, and notably that the
SNPs were more associated with expression of diabetes-
associated genes in metabolically relevant tissues such as
liver, adipose and muscle than in lymphocytes, which are
sometimes used as a surrogate because they are easily
accessible [80-82]. The abundant regulation of these
genes by nutritional status found in our study also
suggests there are likely gene-diet interactions involving
these SNPs [83] that may be a complicating factor in fu-
ture human studies to assess the functional implications
of the associated SNPs.
Conclusions
As SNPs may affect the regulation of genes up to 1 Mb
away [84], future studies should examine the regulation
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identify other possible candidates. Future studies should
also examine the regulation of the remaining newly
discovered type 2 diabetes-associated genes and their
neighbours. Studies to discover how the type 2 diabetes-
associated GWAS SNPs affect the regulation of nearby
genes to promote diabetes will be important to realize
the value of the GWAS studies, however our findings
suggest that such studies will need to be carried out in




Female C57BL/6 J mice were housed in an environmen-
tally controlled facility with 14 hour light cycles (7 am -
9 pm) with unlimited water and were fed either a standard
rodent chow (LabDiet 5010, Jamieson’s Pet Food
Distributors, Delta, BC, Canada) or a diet containing 60%
calories from fat (primarily lard) and 20% calories from
sugar (sucrose and maltodextrin; D12492, Research Diets,
New Brunswick, NJ) from weaning. Mice were sacrificed
at 8 weeks of age by CO2 asphyxiation. Mice were
sacrificed either after a physiological 4 hour fast (9 am -
1 pm) or at 9 am without fasting, as indicated. Tissues
were rapidly collected and flash frozen in liquid nitrogen.
All procedures were approved by the UBC Committee on
Animal Care and were performed according to Canadian
Council on Animal Care guidelines.
Pancreatic islet isolation
Islets were isolated from chow-fed female C57BL/6 J
mice by collagenase digestion, using previously described
modifications [32] of the filtration method reported by
Salvalaggio et al. [85]. We handpicked islets into dishes
of RPMI media (Invitrogen, Burlington, ON, Canada)
containing either 5 mM glucose or 25 mM glucose. Al-
though the mice were not fasted prior to islet isolation,
the islets were incubated in these conditions overnight
at 37°C and 5% CO2 prior to RNA isolation. Experiments
were performed in triplicate; each replicate comprised of
50 islets from each of 2 mice, for a total of 100 islets per
replicate.
Measurement of gene expression
RNA extraction and cDNA synthesis were performed as
described [37]. Primers were designed for all the genes
from the first waves of type 2 diabetes GWAS for which
there was no other evidence of their potential role in
type 2 diabetes. Primers were designed to span an intron
and to be located in exons common to all isoforms for
any genes with alternatively spliced forms, except for
Cdkn2a which has two well characterized isoforms, Arf
and Cdkn2a, for which specific primers were generated.The primer sequences used for each gene are provided
in Additional file 1: Table S1. Because these studies were
performed over a span of several months, and in con-
junction with other studies [37], the sample numbers
varied between genes (e.g. due to the addition of new
samples or when samples were completely used).
Gene expression was assessed by real-time quantitative
reverse transcription PCR (qPCR) using SYBR Green I-
based detection (PerfeCTa SYBR Green FastMix, Quanta
Biosciences, Gaithersburg, MD), as previously described
[37]. We confirmed that only a single product was amp-
lified from all samples through melt-curve analysis in
addition to the direct visualization of PCR amplification
products on an agarose gel prior to real-time analysis.
Gapdh was selected as the reference gene as its exp-
ression was more consistent than β-actin (Actb),
Cyclophilin (Ppib), Arbp, and 18S RNA across the differ-
ent experimental conditions and tissues.
Delta Ct (ΔCt) values were calculated by subtracting
the cycle threshold (Ct) value for each gene from the Ct
value of the control gene amplified contemporaneously.
Delta delta Ct (ΔΔCt) values for each sample were
calculated by subtracting the ΔCt of each sample from
the average ΔCt of the fasted mice consuming chow
(control) group or the islets incubated in 5 mM glucose.
For each gene, negative controls included both a no re-
verse transcriptase (no RT) and no template control
(water).
For the tissue distribution, genes were considered
expressed if the Ct value was at least 2 cycles lower (i.e.
higher expression) than the lowest value in the negative
controls, which was typically undetected. To examine
the relative expression levels of each gene across the
tissues in which it is expressed, we calculated the ave-
rage Ct value for all the tissues that each gene is expressed
in. Tissues with at least a 5-fold higher (2.3 cycles lower)
expression than the average across tissues are shown as
relatively “high” expression of that gene, while tissues
where expression was more than 5-fold lower (Ct values >
2.3 cycles higher) than the average are indicated as hav-
ing relatively “low” expression of that gene. For each
gene, these calculations permit the comparisons of the
same gene between tissues, however due to likely vari-
ation in primer efficiency, comparisons cannot be made
between genes.
Statistical analysis
The study was comprised of three groups: two experi-
mental groups (non-fasted chow-fed and fasted high fat
diet-fed) each compared to a single control group (fasted
chow-fed). Changes in gene expression within liver, adi-
pose tissue, brain and hypothalamus, were compared
using non-parametric Mann–Whitney U-tests for each
of the experimental groups compared to the controls
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was chosen over the Kruskal-Wallis test because the
comparison between the fasted high fat diet-fed and
non-fasted chow-fed mice was not meaningful, as both
fasting and diet conditions differed between these two
groups. Unadjusted P-values are presented [86]. Comparisons
between islets incubated in low and high glucose were
performed by Student’s t-test. Statistics were performed on the
ΔΔCt values, prior to conversion to fold-change [37,87] using
Prism (GraphPad Software). Data are shown as fold change,
calculated as 2ΔΔCt, with the upper and lower limits calculated
as 2ΔΔCt ± its standard error, respectively [87].
Additional file
Additional file 1: Table S1. Primer sequences.
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